Research Paper Volume 12, Issue 6 pp 4931—4944
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on plasma Epstein–Barr virus DNA level after induction chemotherapy
Figure 3. Kaplan–Meier PFS (A), OS (B), LRFS (C), and DMFS (D) curves for the subgroup of 370 NPC patients with undetectable EBV DNA level after induction chemotherapy stratified by CCD < 160 mg/m2, and CCD ≥ 160 mg/m2. Abbreviations: PFS = progression-free survival; OS = overall survival; LRFS = local-regional relapse-free survival; DMFS = distant metastasis-free survival; NPC, nasopharyngeal carcinoma; CCD = cumulative cisplatin dose.